HomeProductsBioactive CompoundsMetabolic EnzymesPDEZatolmilast
Chemical structure of CAS 1606974-33-7

Zatolmilast

CAS No.1606974-33-7
MDL No.N/A
MFC21H15ClF3NO2
MW405.80
InChI KeyLTSUMTMGJHPGFX-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1606974-33-7
Product NameZatolmilast

Biological Targets

PDE4D

Associated Conditions

cognitive disorder·Alzheimer disease·fragile X syndrome
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.

Journal of medicinal chemistry • Vol. 62, Issue 10 • 2019
PMID: 31013090PMC: PMC7444661DOI: 10.1021/acs.jmedchem.9b00193

Genetic Association of Phosphodiesterases With Human Cognitive Performance.

Frontiers in molecular neuroscience • Vol. 12 • 2019
PMID: 30800055PMC: PMC6376954DOI: 10.3389/fnmol.2019.00022

Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3.

Human molecular genetics • Vol. 26, Issue 20 • 2017
PMID: 29016851DOI: 10.1093/hmg/ddx271

Documentation